Tag: pain management

18 posts found

FDA Approves Novel Non-Opioid Journavx for Moderate to Severe Pain

A first-in-class medication, Journavx targets pain-signaling pathways involving sodium channels.

A compound opioid/NOP receptor agonist demonstrated pain relief with a safety profile comparable to placebo.

A new study uses data from 583,000 group health patients with chronic noncancer pain.

Approximately 21% of adults experienced chronic pain in 2021, with greater prevalence among certain demographics.

A new combination of acetaminophen and ibuprofen will soon hit the market.

Extended physical medicine was 5-9 times as common in claims with multiple providers.

Two new studies highlight marijuana’s analgesic effects.

The potential for low amniotic fluid can cause significant health issues.

A systematic review from the Annals of Internal Medicine evaluates different cannabis formulations.

Artri Ajo King contains undeclared diclofenac, creating safety concerns.

Undeclared muscle relaxants and anti-inflammatory drugs could interact with a patient’s care.

VX-548 delivered significant improvements in pain with few adverse events.

A new study found that VR sessions averaged a 40% reduction in pain and decreased opioid use.

A new naloxone drug and a new opioid-NSAID combination.

A WCRI study found that in some states 17% of workers receive topical analgesics.

1 2 Next